Optimization of an integrin enhancing molecule for the treatment of duchenne muscular dystrophy
Ended Project Grant Awarded Last action
- Award ID
- R42OD030543
- Recipient
-
Strykagen Corp UEI GZYNUKFEJRN5
- Awarding agency
-
Aggregate Financial Assistance Data
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,004,848
Award facts
- Assistance listing
- 93.351 Research Infrastructure Programs
- Completion date
- Originally
- Funding
-
- $2,252,422.00 Federal
- $752,426.00 Non-federal
- Funding agency
- Office of the Director National Institutes of Health, Department of Health and Human Services
- Place of performance
- Reno, NV 89557, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $752,426 | $0 | |
| Amendment | $752,426 | $752,426 | |
| Original award | $747,570 | $0 |
Quick answers
Who received award R42OD030543?
R42OD030543 was awarded to Strykagen Corp by Aggregate Financial Assistance Data (National Institutes of Health) on April 1, 2015.
How much is award R42OD030543 worth?
$3,004,848 has been obligated on R42OD030543: $2,252,422 in federal funding and $752,426 in non-federal funding.
Which agency awarded R42OD030543?
Aggregate Financial Assistance Data (National Institutes of Health) awarded R42OD030543, with funding from Office of the Director (National Institutes of Health).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award